GlassScriptPhysician profile
Ken Masui Fujimura
NPI 1629426630
$8,705.80
in general payments reported to CMS, 2019-2025
62 companies · $2,535 in 2025
The $2,535 reported for 2025 was more than what 76% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.70 · 2021: $506 · 2022: $1,395 · 2023: $1,802 · 2024: $2,431 · 2025: $2,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,739 · Education: $28.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,738.86 |
| Education | $28.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $994.38 | 2021-2025 | Rystiggo, Zilbrysq, Fintepla |
| Abbvie INC. | $935.95 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $763.86 | 2022-2025 | Nuplazid, Daybue |
| Biogen, INC. | $756.53 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Alexion Pharmaceuticals, INC. | $581.57 | 2022-2025 | Ultomiris, Soliris |
| Lilly USA, LLC | $390.86 | 2022-2025 | Amyvid, Kisunla, Emgality |
| Jazz Pharmaceuticals INC. | $324.68 | 2022-2025 | |
| Pfizer INC. | $275.98 | 2023-2025 | |
| Eisai INC. | $273.34 | 2023-2025 | |
| Neurelis, INC. | $193.43 | 2020-2025 | Valtoco |
| Sk Life Science, INC. | $189.00 | 2023-2025 | |
| Amneal Pharmaceuticals LLC | $178.24 | 2022-2025 | Crexont, Rytary |
| Teva Pharmaceuticals USA, INC. | $173.75 | 2021-2025 | Austedo Xr, Austedo Xr |
| Lundbeck LLC | $171.45 | 2023-2025 | Vyepti |
| Amgen INC. | $166.51 | 2021-2025 | Uplizna, Aimovig |
Show all 62 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ken Fujimura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.